MedTech Dive November 7, 2025
The company will use the money to accelerate pivotal trials and prepare for commercial launch of the Stentrode BCI system.
Dive Brief:
- Synchron has raised $200 million to support commercialization of its brain computer interface platform, the company said Thursday.
- The Series D round will fund preparations to launch Synchron’s first-generation platform, which translates brain activity into digital commands without open-brain surgery, and development of a new interface.
- Synchron’s funding moves investment in BCI companies in 2024 and 2025 beyond $1 billion, with the round adding to financings at Blackrock Neurotech, Neuralink and Precision Neuroscience.
Dive Insight:
The BCI companies are developing devices that capture and interpret signals from the brain to trigger an action, such as hands-free...
Today's Sponsors
Today's Sponsor